[HTML][HTML] Therapeutic potential of resveratrol in COVID-19-associated hemostatic disorders

R Giordo, A Zinellu, AH Eid, G Pintus - Molecules, 2021 - mdpi.com
Coagulation disorders, endotheliopathy and inflammation are the most common hallmarks
in SARS-CoV-2 infection, largely determining COVID-19's outcome and severity …

[HTML][HTML] Pharmacological agents targeting thromboinflammation in COVID-19: review and implications for future research

B Bikdeli, MV Madhavan, A Gupta… - Thrombosis and …, 2020 - thieme-connect.com
Coronavirus disease 2019 (COVID-19), currently a worldwide pandemic, is a viral illness
caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The …

Flavonoids as a therapeutical option for the treatment of thrombotic complications associated with COVID‐19

JP Quintal Martínez… - Phytotherapy …, 2023 - Wiley Online Library
The SARS‐CoV‐2 outbreak has been one of the largest public health crises globally, while
thrombotic complications have emerged as an important factor contributing to mortality …

The emerging threat of (micro) thrombosis in COVID-19 and its therapeutic implications

JD McFadyen, H Stevens, K Peter - Circulation research, 2020 - Am Heart Assoc
The recent emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
and the ensuing global pandemic has presented a health emergency of unprecedented …

COVID-19 and thrombosis: From bench to bedside

MAM Ali, SA Spinler - Trends in cardiovascular medicine, 2021 - Elsevier
Abstract Coronavirus disease of 2019 (COVID-19) is the respiratory viral infection caused by
the coronavirus SARS-CoV2 (Severe Acute Respiratory Syndrome Coronavirus 2). Despite …

[HTML][HTML] The use of the anticoagulant heparin and corticosteroid dexamethasone as prominent treatments for COVID-19

HA Braz-de-Melo, SS Faria… - Frontiers in …, 2021 - frontiersin.org
COVID-19 is spreading worldwide at disturbing rates, overwhelming global healthcare.
Mounting death cases due to disease complications highlight the necessity of describing …

[HTML][HTML] The impact of SARS-CoV-2 infection on blood coagulation and fibrinolytic pathways: a review of prothrombotic changes caused by COVID-19

M Bahraini, A Dorgalaleh - Seminars in Thrombosis and …, 2022 - thieme-connect.com
The cardinal pathology of coronavirus disease 2019 (COVID-19) is a primary infection of
pulmonary tract cells by severe acute respiratory syndrome coronavirus 2, provoking a local …

COVID-19 and hypercoagulability: a review

A Kichloo, K Dettloff, M Aljadah… - Clinical and Applied …, 2020 - journals.sagepub.com
Thrombotic complications of the novel coronavirus (COVID-19) are a concerning aspect of
the disease, due to the high incidence in critically ill patients and poor clinical outcomes …

COVID–19-associated coagulopathy: An exploration of mechanisms

ME Colling, Y Kanthi - Vascular Medicine, 2020 - journals.sagepub.com
An ongoing global pandemic of viral pneumonia (coronavirus disease [COVID-19]), due to
the virus SARS-CoV-2, has infected millions of people and remains a threat to many more …

[HTML][HTML] The importance of nutraceuticals in COVID-19: What's the role of resveratrol?

E Domi, M Hoxha, E Kolovani, D Tricarico… - Molecules, 2022 - mdpi.com
Since COVID-19 has affected global public health, there has been an urgency to find a
solution to limit both the number of infections, and the aggressiveness of the disease once …